Inventor

FURET PASCAL

FR97 patents

⚠️ This page may combine multiple inventors who share the name “FURET PASCAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FURET PASCAL

NOVARTIS AG

Pyrazole derivatives and processes for the preparation thereof

Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Bicyclic amides as kinase inhibitors

1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors

Anthranilic acid amides and the use thereof as medicaments

Inhibitors of tyrosine kinases

VEGF receptor tyrosine kinase inhibitors

VEGF receptor tyrosine kinase inhibitors

Pyrrolopyrimidine derivatives having pharmacological activity

Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors

4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives

Pyrrolopyrimidine derivatives having pharmacological activity

Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases

Pyrirnidinyl aryl urea derivatives being FGF inhibitors

1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases

Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases

1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors

Inhibitors of tyrosine kinases

Purine derivatives and processes for their preparation

2-amino-6-anilino-purines and their use as medicaments

Oxazolidin-2-one compounds and uses thereof

Use of inhibitors of the activity or function of PI3K

Inhibitors of tyrosine kinases

Pharmaceutical combinations

Phenylacetamides suitable as protein kinase inhibitors

CIBA GEIGY CORP

Substituted benzazepinones

N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids

Benzazepinone derivatives

N-aralkyl-and N-heteroaralkyl-aminoalkanephosphinic acids

BUSCHMANN NICOLE

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide

FURET PASCAL

Pyrazolopyrrolidine compounds

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

1H-imidazo[4,5-c]quinolinone derivatives

FAIRHURST ROBIN ALEC

Pyrrolidine-1,2-dicarboxamide derivatives

Pyrrolidine-1,2-dicarboxamide derivatives

DING QIANG

Compounds and compositions as protein kinase inhibitors

CANCER RES CAMPAIGN TECH

Inhibitors of the interaction between P53 and MDM2

SCHERING AG

N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF

GARCIA-ECHEVERRIA CARLOS

1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors

BOLD GUIDO

Pyrimidinyl aryl urea derivatives being FGF inhibitors

IRM LLC

Methods and compositions as protein kinase inhibitors

BERGHAUSEN JOERG

Substituted isoquinolinones and quinazolinones

CARAVATTI GIORGIO

Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives

GUAGNANO VITO

Pyrrolidine-1,2-dicarboxamide derivatives

DODD STEPHANIE KAY

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

ELANCO TIERGESUNDHEIT AG

Compounds